Industry Insights

  1. Patient Input Is A Must — Even Under Time And Money Constraints 12/4/2025

    Stacie J. Bell, PhD, chief clinical research officer of Lupus Therapeutics, discusses the positive impacts patient advocacy groups can have on patient recruitment, patient retention, protocol design, and more.

  2. From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials 12/3/2025

    Discover how pharma R&D is moving from traditional compute clusters to AI-driven HPC ecosystems and hybrid architectures that combine on-premise supercomputing with elastic cloud infrastructure. 

  3. How To Capture Growth In The Expanding Metabolic Drug Market 12/2/2025

    Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.

  4. The Impact Of Expert PK/PD Modeling In Psychedelic Research 12/2/2025

    Model-informed development that integrates preclinical and literature-based data is enabling smarter predictions of exposure and safety, transforming psychedelic research and advancing clinical innovation.

  5. Need An Investigator? There's An APP — Advanced Practice Provider — For That 12/1/2025

    Fewer available principal investigators (PIs) is not a new problem for clinical research, but it does necessitate some new and creative solutions. Learn how advanced practice providers (APPs) might help fill the PI gap.

  6. Modern Data Platform Strategies That Accelerate Clinical Development 11/26/2025

    A modern data platform is essential for clinical research because it unifies fragmented data, embeds governance, and enables faster, more reliable decision-making.

  7. Digital Biomarkers Are Reshaping Alzheimer's Patient Experience And Data 11/26/2025

    Cognito CEO Christian Howell shares how EEG and digital biomarkers are reshaping recruitment, patient experience, and the quality of study data in Alzheimer’s research.

  8. An FDA First: Dompé Shares Experience Of Securing A Commissioner's National Priority Voucher 11/25/2025

    Dompé Chief Development Officer Ahmed Enayetallah reveals how the team earned the FDA's new Commissioner’s National Priority Voucher.

  9. ESMO Congress 2025: Highlights From Berlin 11/24/2025

    Turn the insights from this year’s ESMO into action by partnering to accelerate innovation through smarter trial design, stronger biomarker planning, and truly global collaboration.

  10. A Tale Of Two Sites: How FastWave Ran Trials In Distinct Locales 11/24/2025

    No two sites are the same. Discover how FastWave Medical chose its global sites, and learn best practices on who to partner with and how.